Artificial Intelligence has officially entered a moment of reckoning. With global AI-related equities erasing over $1 trillion in market value, macroeconomic watchdogs like the International Monetary Fund (IMF), legendary hedge fund billionaire Ray Dalio, and seasoned Wall Street experts are sounding the alarm louder than ever. As speculative fervor crashes into cold economic reality, Indian retai...

In the ever-evolving landscape of global economics and cross-border finance, the philosophy that capital is fundamentally a free bird rather than a prisoner continues to dictate market movements, regulatory postures, and investor sentiment. As institutional and retail portfolios increasingly navigate complex macroeconomic headwinds, understanding the frictionless nature of modern liquidity has nev...

The benchmark indices remained under pressure on June 23, falling 1.16 percent amid weak market breadth. About 2,171 shares declined compared to 831 advancing shares on the NSE. The market is expected to consolidate with range-bound trading as long as it trades below the previous week's high. Below are some short-term trading ideas to consider:Amol Athawale, VP Technical Research at Kotak Securiti...

Nifty IT jumped more than 3 percent on Monday, with largecap shares such as Infosys and midcap stocks including Persistent Systems surging up to 5 percent, as a global rally in artificial intelligence-linked shares spilled over to Indian markets. Indian IT stocks bucked weakness across most sectors, making Nifty IT the best-performing sectoral index by a wide margin, while benchmark indices and mo...

Dilip Shanghvi is moving ahead with what could become his biggest deal yet, with a binding offer of nearly $13 billion submitted for US-based Organon & Co, an Economic Times report said on Friday. The proposed acquisition is part of Sun Pharmaceutical Industries' broader push to evolve from an Indian generics leader into a global branded and innovation-driven drugmaker.Sun Pharma, India's largest ...